UBS Group
CHAC.U

UBS Group’s Chardan Healthcare Acquisition Corp. CHAC.U Stock Holding History

UBS Group’s Portfolio CHAC.U Stock Details CHAC.U Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,661
Closed -$20K – 8765
2019
Q3 		$20K Hold
1,661
– – ﹤0.01% 6756
2019
Q2 		$17K Hold
1,661
– – ﹤0.01% 6747
2019
Q1 		$17K Hold
1,661
– – ﹤0.01% 6461
2018
Q4 		$17K Buy
+1,661
New +$16.6K ﹤0.01% 6924

UBS Group's CHAC.U Position: Q4 2019 in Review

UBS Group sold out of Chardan Healthcare Acquisition Corp. (CHAC.U) in Q4 2019, closing a stake of 1,661 shares — an estimated $20K sold.

UBS Group first reported a position in CHAC.U in Q4 2018 and held it in 4 quarters. The position peaked at $20K in Q3 2019. 0 funds tracked by Wall St. Rank hold CHAC.U as of Q4 2019.

  • UBS Group reported no remaining Chardan Healthcare Acquisition Corp. position as of Q4 2019 after selling out during the quarter.
  • UBS Group sold 1,661 Chardan Healthcare Acquisition Corp. shares in Q4 2019, an estimated $20K.
  • UBS Group first reported a position in Chardan Healthcare Acquisition Corp. in Q4 2018 and held it in 4 quarters.
  • UBS Group's Chardan Healthcare Acquisition Corp. position peaked at $20K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition Corp. as of Q4 2019.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.